Study to Compare the Efficacy of Mycophenolate Mofetil in Systemic Sclerosis Related Early Interstitial Lung Disease

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
Systemic sclerosis is a multisystem disease and can involve the lungs in the form of ILD. Lung involvement is the most common cause of death in these patients. The present study is performed to study the efficacy of oral mycophenolate mofetil in treating early and mild ILD in patients of SSc. The efficacy and side effects of mycophenolate mofetil will be compared with that of oral placebo.
Epistemonikos ID: 8e4d329a8d23247ddfee0bbaf5d997f33c26019b
First added on: Jun 14, 2024